Massachusetts General Hospital; Harvard Medical School
- Advisory Board: Cephalon, Inc.; Eli Lilly and Company; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Novartis Pharmaceutical Corporation; Pfizer Inc; Shire Pharmaceuticals Inc.
- Research Support: Cephalon, Inc.; Eli Lilly and Company; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; National Institute of Mental Health (NIMH); Novartis Pharmaceutical Corporation; Pfizer Inc; Shire Pharmaceuticals Inc.
- Speakers Bureau: Eli Lilly and Company; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.